Health Cases To Watch In 2009

Law360, New York (December 3, 2008, 12:00 AM EST) -- Health care attorneys and their clients are anticipating sweeping reforms from the Obama administration in 2009 and will be watching cases that could have far-reaching impacts on preemption in drug-labeling liability and damages for generic drug companies, attorneys say.

Likewise, attorneys predict plenty of fertile ground for litigation in mainstay areas such as Medicare fraud, as well as new arenas such as hospital bond-related litigation and biologic and stem-cell patents.

Wyeth v. Levine

In what has been dubbed the mother of all preemption cases, the Supreme...
To view the full article, register now.